Thursday, April 26, 2018
 
 
Company News: Page (1) of 1 - 01/13/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
North America will remain the Most Attractive Market for Vitamins and Derivative Over 2026

(January 13, 2018)

Rockville, MD, Jan. 13, 2018 (GLOBE NEWSWIRE) -- According to a new report published by Fact.MR, the global vitamins and derivatives market is expected to surpass 165,000 tons by the end of 2026 in terms of volume. During the forecast period (2017-2026), the market is projected to exhibit a CAGR of 3.5% in term of value. Rising health awareness among consumers, increasing demand for healthy and functional food, expanding geriatric population are some of important factors likely to influence the global consumption of vitamins and derivatives during the review period. Moreover, increased demand for products with higher nutritional content is expected to reflect favorably on the market. In has been observed that, use of vitamin supplements has grown notably in the countries such as Brazil, China, Philippines and India, which has propelled the market further.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=380

Sufficient intake of vitamins and derivatives is important for maintaining a healthy body and preventing diseases that occur primarily due to weakness or malnourishment.  Vitamins and derivatives are being added to a variety of food products owing to rapid consumer inclination towards product that are healthy. Also, changing lifestyle and emerging fast-food culture is making intake of dietary supplements essential to ensure balance diet. Growing importance of maintaining a healthy lifestyle is also driving the demand for vitamin supplements. Modern consumers want to lead a healthy and active life and thereby seek food products that can help them achieve their daily dietary goals.

Use of vitamins and derivatives is also increased in pharmaceutical products as they have the potentials of curing various metabolic syndrome diseases. Increased emphasis on towards preventive healthcare is fueling demand for value-added products. Vitamins and derivatives are available in the form of gummies and softgels, capsules, tablets, oral liquid, and powder.



Browse Full Report with TOC- https://www.factmr.com/report/380/vitamins-derivatives-market

Key Insights from the Report Include:

1- Based on target group, the adult women segment is expected to hold its dominant position over 2026. The segment currently represents for more than 51% revenue share of the global market and expected to exhibit a CAGR of 2.8% during the assessment period

2- Consumption of vitamins and derivatives is relatively higher among adult women. This is primarily owing to a greater need for nutrition in adult women. Moreover, women all over the world are becoming increasingly conscious about their health and wellbeing.

3- Among regions, North America is expected to dominate the global vitamins and derivatives market in 2018, and the trend is likely to continue throughout the forecast period.

4- On the basis of product type, the Vitamin B segment is expected to remain highly attractive in 2018 and beyond. Currently, the segment is command for over one-fourth revenue share of the global market and expected to reach a market valuation in excess of US$ 7,300 Mn by the 2026. Over the course the forecast period, the segment is anticipated to grow by US$ 297.7 Mn annually.

5- On the basis of end use industry, the food and beverage segment is likely to retain its top position over 2026. By the end of 2026, this segment is estimated to surpass a market valuation of US$ 6,900 Mn, reflecting an above-average CAGR.

Global Market for Vitamins and Derivatives: Competition Tracking

Fact.MR in its report has profiled key market players, which include Herbalife, ADM, Abott Laboratories, Glanbia, Pfizer, Lonza Group Ltd, Sanofi, BoehringerIngelheim Consumer Health Care, CSPC Pharmaceutical Group Limited, Adisseo France S.A.S, Amway, Glanbia PLC, DSM, GlaxoSmithKline, Bayer, Jubilant Life Sciences Limited, Atrium Innovations, Inc., Schiff Nutrition International, Inc, Fermenta Biotech Ltd., and Bactolac Pharmaceutical, Inc. 

Request Discount on Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=380

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

CONTACT: Mr. Rohit BhiseyFact.MR11140 Rockville PikeSuite 400Rockville, MD 20852United StatesEmail: [email protected]: https://www.factmr.com/

Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Centene Corporation Reports 2018 First Quarter Results And Adjusts 2018 Guidance
  • "The Future of Getting Old" - With Old Age, New Possibilities
  • Analysis of Global "Medical Device & Accessories Market" Scope | Set for Rapid Growth 6.53% of CAGR during 2018 to 2023 | Topmost Players, Top Regional Trend & Segments | MarketResearchFuture.com
  • Pain Management Device Market Factor Analysis 2018 - Technological and Product Development to Drive the Global Industry by 2023
  • Global Medical Device Market 2018 with Forecasts to 2023 - Driven by Healthcare Expenditure / Technological Development / Aging Population / Chronic Diseases

    Cancer
  • World “Americas Interventional Radiology” Market Competitive Landscape with Phenomenal Growth CAGR 5.12% MRFR Unleashing Market Forecast by 2023
  • Quality Cancer Care: Not Just a Matter of Anti-cancer Medicines
  • Global Biosensors Market 2018-2027: Rising Geriatric Population and Rapid Incorporation of Biosensing Technologies in Non-Medical Applications
  • "21+ Reasons Why" Showcases Support for Tobacco 21
  • Samsung BioLogics becomes the first in the South Korean pharma industry to achieve ISO 22301 Certificate
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines